Cx43 has been considered as a therapeutic target for multiples diseases, including lung cancer, skin disorders, corneal damage, ischemic heart injury, etc. However, inhibiting Cx43 function could be beneficial for preventing tumor cell growth or for improving tissue healing yet may have negative side effects due to its multifunctionality and direct impact on tissue homeostasis. The gene discussed is GJA1; the disease is lung cancer.